BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 34753774)

  • 1. Oncogenic circRNA C190 Promotes Non-Small Cell Lung Cancer via Modulation of the EGFR/ERK Pathway.
    Ishola AA; Chien CS; Yang YP; Chien Y; Yarmishyn AA; Tsai PH; Chen JC; Hsu PK; Luo YH; Chen YM; Liang KH; Lan YT; Huo TI; Ma HI; Chen MT; Wang ML; Chiou SH
    Cancer Res; 2022 Jan; 82(1):75-89. PubMed ID: 34753774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.
    Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H
    Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
    Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
    Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis.
    Wei D; Sun L; Feng W
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
    Cui D; Qian R; Li Y
    Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis.
    Tan Z; Cao F; Jia B; Xia L
    Thorac Cancer; 2020 Aug; 11(8):2224-2236. PubMed ID: 32524752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis.
    Zheng S; Wang C; Yan H; Du Y
    Bioengineered; 2021 Dec; 12(1):8347-8357. PubMed ID: 34592879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa_circ_0016760 exacerbates the malignant development of non‑small cell lung cancer by sponging miR‑145‑5p/FGF5.
    Zhu Z; Wu Q; Zhang M; Tong J; Zhong B; Yuan K
    Oncol Rep; 2021 Feb; 45(2):501-512. PubMed ID: 33416186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soy isoflavone genistein inhibits hsa_circ_0031250/miR-873-5p/FOXM1 axis to suppress non-small-cell lung cancer progression.
    Yu Y; Xing Y; Zhang Q; Zhang Q; Huang S; Li X; Gao C
    IUBMB Life; 2021 Jan; 73(1):92-107. PubMed ID: 33159503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0016760 accelerates non-small-cell lung cancer progression through miR-646/AKT3 signaling in vivo and in vitro.
    Chen S; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y
    Thorac Cancer; 2021 Dec; 12(23):3223-3235. PubMed ID: 34658165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 13. Hsa_circ_0001869 promotes NSCLC progression via sponging miR-638 and enhancing FOSL2 expression.
    Xu P; Wang L; Xie X; Hu F; Yang Q; Hu R; Jiang L; Ding F; Mei J; Liu J; Xiao H
    Aging (Albany NY); 2020 Nov; 12(23):23836-23848. PubMed ID: 33221767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
    Gao P; Wang Z; Hu Z; Jiao X; Yao Y
    J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircRNA_102179 promotes the proliferation, migration and invasion in non-small cell lung cancer cells by regulating miR-330-5p/HMGB3 axis.
    Zhou ZF; Wei Z; Yao JC; Liu SY; Wang F; Wang Z; Chen XF; Lin H; Ye Y; Zheng QF
    Pathol Res Pract; 2020 Nov; 216(11):153144. PubMed ID: 32911346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
    Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging.
    Chen S; Lu S; Yao Y; Chen J; Yang G; Tu L; Zhang Z; Zhang J; Chen L
    Aging (Albany NY); 2020 Jul; 12(14):14329-14340. PubMed ID: 32681720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circ-FOXM1 facilitates cell progression as ceRNA to target PPDPF and MACC1 by sponging miR-1304-5p in non-small cell lung cancer.
    Liu G; Shi H; Deng L; Zheng H; Kong W; Wen X; Bi H
    Biochem Biophys Res Commun; 2019 May; 513(1):207-212. PubMed ID: 30954221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA hsa_circ_0002360 promotes non-small cell lung cancer progression through upregulating matrix metalloproteinase 16 and sponging multiple micorRNAs.
    Zhang Y; Zeng S; Wang T
    Bioengineered; 2021 Dec; 12(2):12767-12777. PubMed ID: 34747300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis.
    Zhang W; Song C; Ren X
    Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.